VPI
MRK icon

Value Partners Investments’s Merck MRK Stock Holding History

Value Partners Investments’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.37M Buy
18,475
+1,032
+6% +$121K 0.17% 65
2026
Q1 		$2.1M Buy
17,443
+576
+3% +$66.5K 0.16% 66
2025
Q4 		$1.78M Buy
16,867
+861
+5% +$80.8K 0.14% 64
2025
Q3 		$1.34M Buy
16,006
+625
+4% +$51.5K 0.11% 69
2025
Q2 		$1.22M Buy
15,381
+862
+6% +$68.5K 0.1% 72
2025
Q1 		$1.3M Buy
14,519
+250
+2% +$23.3K 0.11% 66
2024
Q4 		$1.42M Sell
14,269
-1,104
-7% -$114K 0.8% 46
2024
Q3 		$1.75M Buy
15,373
+80
+0.5% +$9.5K 0.14% 55
2024
Q2 		$1.89M Sell
15,293
-33,679
-69% -$4.34M 0.16% 49
2024
Q1 		$6.45M Sell
48,972
-13,839
-22% -$1.71M 0.53% 23
2023
Q4 		$6.83M Buy
62,811
+11,586
+23% +$1.2M 0.55% 22
2023
Q3 		$5.27M Buy
51,225
+282
+0.6% +$30.4K 0.44% 26
2023
Q2 		$5.88M Buy
50,943
+195
+0.4% +$22.1K 0.47% 24
2023
Q1 		$5.4M Sell
50,748
-21,959
-30% -$2.37M 0.44% 23
2022
Q4 		$8.07M Buy
72,707
+134
+0.2% +$13.7K 0.7% 19
2022
Q3 		$6.26M Buy
72,573
+12,206
+20% +$1.09M 0.63% 21
2022
Q2 		$5.5M Sell
60,367
-798,167
-93% -$70.8M 0.51% 25
2022
Q1 		$70.4M Buy
858,534
+62,515
+8% +$4.93M 5.97% 7
2021
Q4 		$60.8M Buy
796,019
+352
+0% +$28K 4.94% 10
2021
Q3 		$59.4M Buy
795,667
+1,263
+0.2% +$96.1K 5.04% 8
2021
Q2 		$61.7M Buy
794,404
+39,084
+5% +$2.91M 5.03% 10
2021
Q1 		$55.5M Buy
755,320
+299,853
+66% +$22.1M 4.82% 11
2020
Q4 		$35.6M Buy
+455,467
New +$34.8M 3.15% 17

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Value Partners Investments's MRK Position: Q2 2026 in Review

Value Partners Investments increased its Merck (MRK) stake by 5.9% in Q2 2026, buying an estimated $121K and bringing the position to 18,475 shares worth $2.37M. The position accounts for 0.17% of the portfolio, ranked #65.

Value Partners Investments first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. The position peaked at $70.4M in Q1 2022. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Value Partners Investments held 18,475 shares of Merck worth $2.37M as of Q2 2026.
  • Value Partners Investments bought 1,032 Merck shares in Q2 2026, an estimated $121K.
  • Merck made up 0.17% of Value Partners Investments's portfolio in Q2 2026, its #65 holding.
  • Value Partners Investments first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
  • Value Partners Investments's Merck position peaked at $70.4M in Q1 2022.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Value Partners Investments's 13F filing for Q2 2026, filed 15 Jul 2026.